1) Leung, N., Ramirez-Alvarado, M., Nasr, S., Kemp, B., Johnson, G. (2017). Detection of ALECT2 amyloidosis by positron emission tomography- computed tomography imaging with florbetapir. British Journal of Haematology, 177(1), 12.
2) Benson, M. (2003). The hereditary amyloidoses. Best Practice & Research in Clinical Rheumatology, 17(6), 909-927.
3) Benson, M. D., James, S., Scott, K., Liepnieks, J. J., & Kluve-Beckerman, B. (2008). Leukocyte chemotactic factor 2: A novel renal amyloid protein. Kidney International, 74(2), 218-222.
4) Buck, F., Koss, M., Sherrod, A., Wu, A., & Takahashi, M. (1989). Ethnic distribution of amyloidosis - an autopsy study. Modern Pathology, 2(4), 372-377.
5) Desport, E., Bridoux, F., Sirac, C., Delbes, S., Bender, S., Fernandez, B., et al. (2012). AL amyloidosis. Orphanet Journal of Rare Diseases, 7, 54.
6) Dogan, A., Theis, J. D., Vrana, J. A., Jimenez-Zepeda, V. H., Lacy, M. Q., Leung, N., et al. (2010). Clinical and pathological phenotype of leukocyte cell-derived chemotaxin-2 (LECT2) amyloidosis (ALECT2). Amyloid Journal of Kidney Disease, 17, 69-70.
7) Hemminki, K., Li, X., Forsti, A., Sundquist, J., & Sundquist, K. (2012). Incidence and survival in non-hereditary amyloidosis in sweden. Bmc Public Health, 12, 974.
8) Holanda, D. G., Acharya, V. K., Dogan, A., Racusen, L. C., & Atta, M. G. (2011). Atypical presentation of atypical amyloid. Nephrology Dialysis Transplantation, 26(1), 373-376.
9) Hutton, H. L., DeMarco, M. L., Magil, A. B., & Taylor, P. (2014). Renal leukocyte chemotactic factor 2 (LECT2) amyloidosis in first nations people in northern british columbia, canada: A report of 4 cases. Amyloid Journal of Kidney Disease.
10) KYLE, R., LINOS, A., BEARD, C., LINKE, R., GERTZ, M., OFALLON, W., et al. (1992). Incidence and natural-history of primary systemic amyloidosis in olmsted county, minnesota, 1950 through 1989. Blood, 79(7), 1817-1822.
11) Larsen, C. P., Kossmann, R. J., Beggs, M. L., Solomon, A., & Walker, P. D. (2014). Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis. Kidney International, 86(2), 378-382.
12) Larsen, C. P., Walker, P. D., Weiss, D. T., & Solomon, A. (2010). Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies. Kidney International, 77(9), 816-819.
13) Mereuta, O. M., Theis, J. D., Vrana, J. A., Law, M. E., Grogg, K. L., Dasari, S., et al. (2014). Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the united states. Blood, 123(10), 1479-1482.
14) Murphy, C. L., Wang, S., Kestler, D., Larsen, C., Benson, D., Weiss, D. T., et al. (2010). Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: A case series. American Journal of Kidney Diseases, 56(6), 1100-1107.
15) Picken, M. M. (2014). Alect2 amyloidosis: Primum non nocere (first, do no harm). Kidney International, (86), 229.
16) Pinney, J. H., Smith, C. J., Taube, J. B., Lachmann, H. J., Venner, C. P., Gibbs, S. D. J., et al. (2013). Systemic amyloidosis in england: An epidemiological study. British Journal of Haematology, 161(4), 525-532.
17) Robert, K. A., & GERTZ, M. A. Systemic amyloidosis.
18) Said, S. M., Sethi, S., Valeri, A. M., Chang, A., Nast, C. C., Krahl, L., et al. (2014). Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis. Kidney International, 86, 370-377.
19) Said, S. M., Sethi, S., Valeri, A. M., Leung, N., Cornell, L. D., Fidler, M. E., et al. (2013). Renal amyloidosis: Origin and clinicopathologic correlations of 474 recent cases. Clinical Journal of the American Society of Nephrology, 8(9), 1515-1523."
20) Shiller, M. S., Dogan, A., & Highsmith, W. E. (Eds.). (2011). Laboratory methods for the diagnosis of Hereditary amyloidoses (Dr. Svetlana Sarantseva (Ed.) ed.). Croatia: InTech.
21) Sipe, J. D., Benson, M. D., Buxbaum, J. N., Ikeda, S., Merlini, G., Saraiva, M. J. M., et al. (2012). Amyloid fibril protein nomenclature: 2012 recommendations from the nomenclature committee of the international society of amyloidosis. Amyloid-Journal of Protein Folding Disorders, 19(4), 167-170.
22) von Hutten, H., Mihatsch, M., Lobeck, H., Rudolph, B., Eriksson, M., & Roecken, C. (2009). Prevalence and origin of amyloid in kidney biopsies. American Journal of Surgical Pathology, 33(8), 1198-1205.
23) Vrana, J. A., Theis, J. D., Grogg, K. L., Wu, T., Chandan, V. S., & Dogan, A. (2012). Amyloidosis of the liver: Mass spectrometry-based proteomic analysis reveals diverse etiology associated with distinct histological features. Modern Pathology, 25, 425A-425A.